Companies

Achira is building atomistic foundation simulation models to power the future of drug discovery.

Owkin is building the first BASI to unlock breakthroughs in therapies, diagnostics, and rejuvenation, while reshaping how humanity understands and engineers biology. Like other frontier AI companies, we believe the leap from narrow tools to true reasoning systems marks the start of a new era — where intelligence is not just assisting scientists but autonomously advancing discovery. Owkin’s moats are structural and compounding. We are creating the only large-scale reasoning model trained native

Opentrons Labworks, Inc., is a disruptive life science company leveraging its integrated lab platform to supercharge the pace of innovation in research and healthcare. Opentrons Labworks is the parent company to business units Opentrons Robotics and Neochromosome. Through Opentrons Robotics, thousands of institutions are automating R&D operations with flexible, easy-to-use liquid handling lab robots. Through Neochromosome, biopharma and biotech at large can benefit from our world-class genome-sc

D. E. Shaw Research (DESRES), based in New York City, develops and uses advanced computational technologies to understand the behavior of biologically and pharmaceutically significant molecules at an atomic level of detail, and to design precisely targeted, highly selective drugs for the treatment of various diseases. Among its core technologies is Anton, a proprietary special-purpose supercomputer that DESRES designed and constructed to vastly accelerate the process of molecular dynamics simul

AI-native pharma company that acquires clinical-stage drugs and develops them faster with proprietary technology

An AI platform that automates clinical trial data cleaning and review for pharmaceutical companies

Utilizing our expertise to provide recruitment solutions to some of the worlds most cutting-edge companies in MedTech and Life Science. Our world-leading team of expert’s passion lies in deliver cutting edge talent solutions to visionary clients, positively impacting human health within a variety of specialisms including: - Biotech - CDMO - CRO - MedTech New York | San Diego | London | Fort Lauderdale | Austin | Leeds | Nottingham

TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure. The company integrates proprietary AI-driven, high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution. TandemAI has built its networked platform from the ground up in the U.S. and China to increase the speed of drug discovery and deliver cost-effective opportunities to its partners and to the global scientific community.

Numenos was founded on the insight that biology lacks the foundational laws that make physics predictive, and we lack the tools to discover them. Medicine today treats diseases as separate, isolated problems. Cancer researchers study cancer. Autoimmune specialists study autoimmune disease. Neurologists study neurological conditions. Each operates in its own silo, learning correlations specific to their disease without discovering the deeper principles that connect them all. This lack of underst

Lifebit powers the federated infrastructure behind national-scale biomedical research. Our platform enables pharma, biobanks, and governments to analyze the world's most sensitive health data — without the data ever leaving its source. Genomics England runs on Lifebit. So do ten of the world's largest biobanks, and research programs spanning the UK, US, and Asia. We built the federated Trusted Research Environment (TRE) from first principles around the ONS Five Safes framework: data stays at s

Transforming Drug Discovery through AxDrug & Synthesis Expertise AxDrug, our state-of-the-art AI engine, revolutionizes the drug discovery landscape by swiftly identifying promising "hit" molecules with unparalleled accuracy. At PozeSCAF, we don't stop at identification. With our in-house chemistry lab, we design, synthesize, and deliver molecules to our clients, analyzing assay results and progressing to the Lead optimization stage. Global Reach, Local Excellence While headquartered in the U

An AI-enabled health data platform that aggregates patient medical records for pharmaceutical research

Stemline Therapeutics develops and manufactures pharmaceutical treatments, including therapies for blood cancers and related conditions.

Rumi Scientific is a research-driven company focused on the discovery of drugs and innovative treatments for human genetic diseases affecting the central nervous system. We have created an exciting human organoid-based platform that can be used for agnostic drug discovery and can be translated at the level of high-throughput screening. We have unlocked the full potential of human organoid technology for the discovery of tomorrow’s therapeutics. Our platform harnesses the power of embryonic ste

Eigen Bio is a biological intelligence company that models the causal logic of biology to predict disease, treatment response, drug targets, and biomarkers. Its platform combines a biological foundation model, Eigen-1, with a multi-omics knowledge graph, Eigenfield. The commercial offering, Eigen ORIGIN, deploys the platform inside customer environments for target and biomarker discovery.

Dante Omics AI merges multiomics data with advanced artificial intelligence to drive innovation in precision medicine. The company leverages its proprietary Dante Platform to provide superior results to clinicians, researchers and individuals. The company continues to pioneer cutting-edge technologies that deepen our understanding of human biology and empower transformative healthcare solutions worldwide.

Biopharma company building focused subsidiaries (Vants) and applying technology across discovery, development and commercialization

Norstella provides artificial intelligence and data analytics platforms for biopharmaceutical companies to support decision-making across drug development and commercialization.

🚀 We are a leading staff augmentation firm specializing in the biotechnology sector. With a commitment to innovation and excellence, we provide tailored workforce solutions that empower biotech companies to navigate the complexities of research, development, and commercialization. 🧬 At Biotech-X our focus is to bridge the talent gap in the biotech industry by delivering highly skilled professionals who drive scientific advancements and operational efficiency. We believe that the right people

Biotia is a health tech company advancing infectious disease diagnostics for challenging infections. As a spinout company of the Jacobs Technion-Cornell Institute at Cornell Tech, Biotia is based in New York City, where it operates a high-complexity, CLIA-certified diagnostic laboratory.

Leucine is an AI-powered platform that helps pharmaceutical manufacturers stay compliant and audit-ready while ensuring the right first-time batch release. Using Leucine, Manufacturing, QA, and QC teams can significantly increase productivity and reduce deviations from cGMP guidelines across thousands of complex regulated workflows from material receipt to batch release. Leucine supports manufacturers across all modalities such as small molecules, biologics, gene therapies, vaccines etc. We h

Intelligencia AI uses artificial intelligence to de-risk drug development. Our platform focuses on estimating the risk of clinical trials, and interpreting the multitude of factors that contribute to that risk. We bridge the gap between innovation and risk reduction, with the ultimate goal of bringing novel therapies to patients faster. Our interdisciplinary team of software engineers, AI practitioners, scientists, and drug developers combines and interprets disparate data across the life scien

Since 2014, Vimachem has been transforming pharmaceutical and biotech manufacturing with the AI-powered, composable Vimachem Pharma MES Platform. Purpose-built for the Life Sciences industry, the platform has been deployed across 200+ pharma sites globally, helping manufacturers boost process efficiency, enhance product quality, and reduce compliance risk and lead times. Smart, flexible, and built with the pharma operator in mind, the Vimachem Pharma MES leverages Artificial Intelligence (AI)

Overview: AccutarBio employs artificial intelligence to revolutionize drug discovery. With capabilities in side chain flexible mode ligand docking, virtual screening, and drug ADME property prediction, Accutar’s platform beats the industry standard in computation-aided drug design. The company’s hybrid based approach, which uses computational drug design followed by wet lab validation, greatly reduces the time and cost necessary for traditional drug discovery efforts. Accutar is committed to bui

Founded in 2017, Redesign Science is a platform biotech working at the interface of physics-based molecular simulation and deep learning to create generative AI for drug discovery. We deploy our platform technology to develop first-in-class Protein Interaction Modulators against validated targets known to drive progression of multiple oncogenic and inflammatory diseases.

We are a dedicated platform that explores the transformative role of AI in drug development and therapeutic decision-making. This page curates the latest news, insights, and breakthroughs at the intersection of data science and pharmacological sciences. Here, you'll find summaries of our apps and others recently published manuscripts, highlights of innovative apps and tools developed for model-informed drug development, and real-world applications of ML/DL in dose optimization, trial simulation,

NYC company founded in 2022 by Joshua Abram, Alan Murray and Alejandro Chavez-Badiola, building an automated, AI-guided IVF laboratory for cell therapies and fertility treatment.

The foundation for the next era of biology

Accelerating Histopathology for Cancer Research

Waypoint Bio is a VC-backed biotech startup building the next generation of cell therapies for solid tumors.

Brainify.AI is an AI biomarker platform for the development of novel treatments for depression that increases the likelihood of new treatment approval and increases drug efficacy. We are members of J&J Labs and Merck DSS. Brainify.AI is backed by Merck GHI Fund, Northpond, and Kodori VC

AI for life sciences documents

Gilgamesh is a clinical-stage biotech whose vision is to reshape how mental illnesses are treated by shifting away from symptom management to a focus on rapid-acting and durable therapies targeting the fundamental drivers of disease. We do this by designing best-in-class new chemical entities (NCEs) acting through proven mechanisms, which are optimized for safety, efficacy, and patient access

Physics-based computational platform for drug discovery and materials science

A drug design company that uses physics-based simulations and AI to design novel small molecules by modeling protein motion at atomic resolution

Ordaōs is a human-enabled, machine-driven drug design company. Our miniPRO™ proteins help drug hunters deliver treatments that are safer and more effective than traditional discovery methods.

Curative genetic medicines for kidney and pancreatic disease using AI and high-throughput screening

OccamzRazor pioneers novel machine learning methods to increase success in drug discovery and development.

EncrypGen makes next-generation software to aide in safely storing and sharing genomic data for research and science, and to allow users to manage their own data and sell it to researchers. Acquired by IndyGeneUS in 2022

Arclio is a clinical-evidence platform for biopharma. It gives regulatory, clinical, and biostatistics teams FDA-defensible answers from their trial data in 30 seconds, not three days. Unlike tools that only show where a number came from, Arclio proves it correct and unaltered through deterministic, re-runnable computations on a tamper-evident evidence chain. The agent runs entirely inside your own infrastructure — no data ever moves. It produces publication-grade charts and an FDA readiness sco

Building from experience with financial market data and predictive models, Deep Nexus is commercializing an Algebraic-Information-Theoretic platform for materials discovery. Φ(M) (phi-M — the information of matter) connects bits to atoms by transforming molecules into precise mathematical objects that collectively define a fixed coordinate system, a map of matter. Navigating this map reveals both known and previously unknown novel materials.

Synapmed is a science-led, AI-native full-service CRO delivering end-to-end solutions across the entire product lifecycle, from protocol design and pre-clinical development through clinical operations, regulatory approval, commercialization, and drug safety. With global operations spanning the USA, Europe, and Asia-Pacific, we unite physicians, pharmacists, scientists, and technologists to advance clinical research, regulatory affairs, and drug safety with precision and speed. Our science-drive

Alchemi accelerates drug development with purpose-built scientific agents. By combining deep scientific expertise with advanced AI, our agents are built for GxP environments and streamline complex workflows across CMC, bioanalysis, clinical development, and regulatory submissions. We are already supporting >3,000 studies, helping life sciences teams bring therapies to market faster, safer, and more efficiently.

Software that automates segmentation and analysis of medical imaging data from CT, MRI, PET, and optical scans to extract radiomic biomarkers for drug discovery and research.

At Synaptrix, we are creating new kinds of AI to push the frontier of non-invasive brain-computer interfaces. We believe that within the next decade, our systems will reach capabilities comparable to implants.

LogicFlo AI is an AI-native platform built for post clinical teams in life sciences (Medical Affairs, Regulatory, Commercial etc.) We help streamline end-to-end scientific workflows, across content creation, review, and compliance for medical information, publications, and training, turning what is typically slow, fragmented, and manual into something fast, structured, and reliable. Built for pharma and biotech teams operating in highly regulated environments, LogicFlo AI is designed to work

OneThree Biotech was born out of the largest precision medicine institute in America with the purpose of decreasing the failure rate of bringing therapeutics to market using biology driven artificial intelligence. Our technology was built in a lab setting; allowing us to engineer our methodologies around real-world results. While working with major biotech and pharma partners; we’ve validated our predictions through work in target discovery, compound and combination therapy identification, toxic

New York company using data and machine learning models to solve small molecule ADMET problems.

Autonomous AI scientists discovering medicines for neuroinflammation and immunology

Company behind ESM3

Superlative Biosciences LLC serves as a professional consultant to companies actively developing medical products. We provide quality and regulatory consulting in the area of biologics, pharmaceuticals, human cell and tissue products, and in vitro diagnostics. Our goal is to help you to move your company's life sciences projects forward from conception to validation, through development, pass regulatory hurdles, and into the marketplace. Services That We Provide ♦ Superlative BioSciences Provi

At Synthesa, we conduct Systematic Literature Reviews, Pairwise and Bayesian Meta Analyses, and Network Meta Analyses using validated AI based workflows, delivering an "AI-as-a-Service" solution for Medical Affairs teams in pharma, biotech, and medical device companies. We also support medtech startups seeking to establish a strong clinical evidence base, as well as research teams and academic institutions. We believe the future of evidence synthesis is not just about keeping pace with scientif

Longevity Vision Fund (LVF) is a venture capital fund that invests in technologies with the potential to disrupt life sciences and healthcare to help people live longer, healthier lives. The fund’s mission is to accelerate longevity breakthroughs, and to make them accessible and affordable to everyone LVF provides venture funding (Series A-C / crossover) to health tech, longevity and biotech companies across the following sectors: - Therapeutic & Drug Delivery Platforms - Medical Technologie

AI infrastructure for biosecurity

Triton Bio is developing novel bioinstruments to accelerate lab workflows, with applications in research and diagnostics

SECA is the world's first cloud-based intelligent investigation and error control software designed exclusively for the pharmaceutical industry. It consists of integrated modules that work together to support quality, compliance, and more efficient and effective error control decision-making. SECA is the industry's first Error control software that uses artificial intelligence, predictive analytics and business intelligence to improve quality decision-making and enable the transition from react

Maps the immune system at single-cell scale with machine learning to guide immunotherapy development

Private deep tech research lab. Building systems that grow, heal, replicate, and adapt.

AI platform (SpliceCore) targeting RNA splicing for oncology and neurodegeneration therapeutics

Biotech developing medicines from insights into gut-brain neural signaling pathways